^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Prostate Cancer |
| Drug: | zoledronic acid (Bone resorption factor inhibitor, Osteoclast inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
Zometa is a bisphosphonate indicated for the treatment of:…Prostate cancer should have progressed after treatment with at least one hormonal therapy.
